Search Results - "Vázquez, Ramiro Núñez"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2

    Protocol for oral implant rehabilitation in a hemophilic HIV-positive patient with type C hepatitis by Castellanos-Cosano, Lizett, Núñez-Vázquez, Ramiro-José, Segura-Egea, Juan-José, Torres-Lagares, Daniel, Corcuera-Flores, José-Ramón, Machuca-Portillo, Guillermo

    Published in Implant dentistry (01-10-2014)
    “…A 46-year-old man with severe hemophilia A, stage A2 HIV infection and chronic hepatitis C genotype 1A, for whom the treatment plan included implant-supported…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Acquired Haemophilia A: A Review of What We Know by Mingot-Castellano, Maria Eva, Rodriguez-Martorell, Francisco Javier, Nunez-Vazquez, Ramiro Jose, Marco, Pascual

    Published in Journal of blood medicine (30-11-2022)
    “…Autoantibodies against plasma coagulation factors could be developed by some individuals inducing severe and sometimes fatal bleedings. This clinical entity is…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Switching hemophilia A patients to rVIII-SingleChain: The Iberian experience by Calvo-Villas, José Manuel, Núñez-Vázquez, Ramiro, Benítez-Hidalgo, Olga, García-Díaz, Covadonga, Galmés, Bernat, Carvalho, Manuela, Serrano-Torres, Pilar, Aznar-Salatti, José, Álvarez-Román, María Teresa

    Published in Medicine (Baltimore) (06-09-2024)
    “…The real-world outcomes of lonoctocog alfa (rVIII-SingleChain), a long-acting factor VIII (FVIII) with a favorable safety and efficacy profile in trials, were…”
    Get full text
    Journal Article
  7. 7

    Factor XIII Deficiency As Underlying Cause Of Unexplained Bleeding by Mercado, Marta Ruiz, Cozzarelli, Silvia Verdesoto, Calderón-Cabrera, Cristina, Vázquez, Ramiro Núñez, Bárcenas, Reyes Jiménez, Garrido, Rosario Pérez, Pérez-Simón, Jose Antonio, Rodríguez Martorell, Francisco Javier

    Published in Blood (15-11-2013)
    “…Factor XIII deficiency (FXIII) is an uncommon coagulation disorder. Congenital FXIII deficiency, generally due to mutations in F13A1 gene, presents with early…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Cathepsin K as a biomarker of bone involvement in type 1 Gaucher disease by Bobillo Lobato, Joaquín, Durán Parejo, Pilar, Núñez Vázquez, Ramiro J., Jiménez Jiménez, Luis M.

    Published in Medicina clínica (English ed.) (05-10-2015)
    “…Gaucher disease is an inherited disorder caused by deficit of acid β-glucocerebrosidase, responsible for the degradation of glucosylceramide to ceramide and…”
    Get full text
    Journal Article
  10. 10

    2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies by Pérez-Fierro, M, Castellanos-Cosano, L, Hueto-Madrid, J-A, López-Jiménez, J, Núñez-Vázquez, R-J, Machuca-Portillo, G

    “…Evaluating 2-years implant loss and marginal bone loss in patients with hereditary coagulopathies, comparing with a healthy control group. 37 implants in 13…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Cathepsin K as a biomarker of bone involvement in type 1 Gaucher disease by Bobillo Lobato, Joaquín, Durán Parejo, Pilar, Núñez Vázquez, Ramiro J, Jiménez Jiménez, Luis M

    Published in Medicina clinica (05-10-2015)
    “…Gaucher disease is an inherited disorder caused by deficit of acid β-glucocerebrosidase, responsible for the degradation of glucosylceramide to ceramide and…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17

    The spectrum of mutations in Southern Spanish patients with hemophilia A and identification of 28 novel mutations by Fernandez-Lopez, O, Garcia-Lozano, , JR, Nunez-Vazquez, R, Perez-Garrido, R, Nunez-Roldan, A

    Published in Haematologica (Roma) (01-05-2005)
    “…The aim of this study was to analyze the mutation pattern causing hemophilia A in a population from Southern Spain. Mutation analysis identified the mutation…”
    Get full text
    Journal Article
  18. 18